Determination of pKa and Degradation Products of the Mutated BRAF Inhibitor Vemurafenib and UPLC Assay in Human Urine

Şanli, Senem and Özdemir, Ayşe and Güven, Gülşen and Gökçe, Süleyman (2020) Determination of pKa and Degradation Products of the Mutated BRAF Inhibitor Vemurafenib and UPLC Assay in Human Urine. Journal of Pharmaceutical Research International, 32 (36). pp. 18-27. ISSN 2456-9119

[thumbnail of Sanli32362020JPRI62926.pdf] Text
Sanli32362020JPRI62926.pdf - Published Version

Download (267kB)

Abstract

In this study, the pKa value of vemurafenib was determined by the dependence of the retention factor on the pH of the mobile phase. The change of pKa in the different acetonitrile fraction ranging between 57.5 and 62.5% (v/v) was studied by using an LC-UV method. Additionally, a simple, reliable, and rapid UPLC method has been developed for the determination of vemurafenib in human urine. Efavirenz was used as an internal standart. For vemurafenib and efavirenz, selectivity factors were found as 1.204. The asymmetry and capacity factors were obtained as 1.100 and 7.532 for vemurafenib.

Vemurafenib was exposed to thermal, photolytic, hydrolytic, and oxidative stress conditions, and the stressed samples were detected by LC/MS/MS method.

Item Type: Article
Subjects: East India Archive > Medical Science
Depositing User: Unnamed user with email support@eastindiaarchive.com
Date Deposited: 10 Apr 2023 08:36
Last Modified: 24 Aug 2024 13:24
URI: http://ebooks.keeplibrary.com/id/eprint/645

Actions (login required)

View Item
View Item